Company Overview - Nightingale Health OYJ has developed an advanced health check solution that detects risks for multiple chronic diseases from a single blood sample, aiming to replace current routine assessments and improve health interventions [5][6] - The company operates globally with a parent company in Finland and subsidiaries in countries including Japan, the United States, Singapore, and the United Kingdom, serving customers in over 34 countries [6] Market Entry - Nightingale Health OYJ has qualified to trade on the OTCQX Best Market, allowing U.S. investors to trade its shares under the symbols "NHLTY" and "NGHLF" [1][2] - The upgrade to the OTCQX Market is significant for companies seeking transparent trading for U.S. investors, as it allows them to utilize home market reporting for compliance [3] Strategic Goals - The CEO of Nightingale Health expressed excitement about trading on the OTCQX, highlighting the U.S. as the world's largest healthcare market and the company's global ambitions [4] - Nightingale Health is in the process of establishing a laboratory in New York, aligning with its global growth strategy [4]